Monitoring, Treatment Resistance, and Treatment Failure in Chronic Myeloid Leukemia
Breaking Barriers to Improved Outcomes
Jorge Eduardo Cortes, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas
John M. Goldman, DM, FRCP, FRCPath, FMedSci
Imperial College
London, United Kingdom
Timothy P. Hughes, MD, MBBS
Centre for Cancer Biology
Adelaide, Australia
Faculty Perspectives by:
Patricia S. Ault, RN, FNP, and Mary Beth Rios, CCRP, RN
The University of Texas MD Anderson Cancer Center
Houston, Texas
Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.
CNE provided by MediCom Worldwide, Inc.
This activity is supported by an unrestricted educational grant from ARIAD Pharmaceuticals, Inc.
Continuing Education
Read More
Review ArticleJorge Eduardo Cortes, MD(1). John M. Goldman, DM, FRCP, FRCPath, FMedSci(2), and Timothy P. Hughes, MD, MBBS(3); Faculty Perspectives by Patricia S. Ault, RN, FNP(1), and Mary Beth Rios, CCRP, RN(1)Read More
